Clinical-Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke

The clinical-diffusion mismatch (CDM) model has been proposed as a simpler tool than perfusion-diffusion mismatch (PDM) to select acute ischemic stroke patients for thrombolytic therapy. We hypothesized that in the 3- to 6-hour time window, the effect of tPA was significantly greater in patients wit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2009-07, Vol.40 (7), p.2572-2574
Hauptverfasser:	EBINGER, Martin, IWANAGA, Takeshi, DONNAN, Geoffrey A, DAVIS, Stephen M, PROSSER, Jane F, DE SILVA, Deidre A, CHRISTENSEN, Soren, COLLINS, Marnie, PARSONS, Mark W, LEVI, Christopher R, BLADIN, Christopher F, BARBER, P. Alan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Double-Blind Method Fibrinolytic Agents - therapeutic use Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Logistic Models Medical sciences Models, Biological Models, Statistical Nervous system (semeiology, syndromes) Neurology Sensitivity and Specificity Stroke - diagnosis Stroke - drug therapy Thrombolytic Therapy Time Factors Tissue Plasminogen Activator - therapeutic use Treatment Outcome Vascular diseases and vascular malformations of the nervous system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!